17.07 +0.60 (3.83%)
AMLN
| Trade AMLN now with |
Stock Details
Last Trade:17.07 Change:+0.60 (3.83%) Prev Close:16.47 Open: 15.68 Days Range:15.60 – 17.08 52 Week Range: 8.03 - 18.30 Volume:4118225 P/E: N/AEPS:-0.70
View AllRecent Alerts 02/09/12
Recent Alert on 02/07/12 at 7:40am
Jefferies Raises Price Target On Amylin Pharmaceuticals (AMLN) to $30 After Q4 Results/Guidance
Jefferies Raises Price Target On Amylin Pharmaceuticals (AMLN) to $30 After Q4 Results/Guidance
Jefferies boosted its estimates and price target on Buy-rated Amylin Pharmaceuticals (NASDAQ: AMLN) from $25 to $30 following Q4 results, with guidance that suggests upside to sales estimates. The firm comments, "AMLN announced 4Q11 and issued... Read More
Recent Alert on 02/07/12 at 7:40am
Jefferies Raises Price Target On Amylin Pharmaceuticals (AMLN) to $30 After Q4 Results/Guidance
Jefferies Raises Price Target On Amylin Pharmaceuticals (AMLN) to $30 After Q4 Results/Guidance
Recent Alert on 02/07/12 at 7:40am
Jefferies Raises Price Target On Amylin Pharmaceuticals (AMLN) to $30 After Q4 Results/Guidance
Jefferies Raises Price Target On Amylin Pharmaceuticals (AMLN) to $30 After Q4 Results/Guidance
Recent Alert on 02/07/12 at 7:40am
Jefferies Raises Price Target On Amylin Pharmaceuticals (AMLN) to $30 After Q4 Results/Guidance
Jefferies Raises Price Target On Amylin Pharmaceuticals (AMLN) to $30 After Q4 Results/Guidance
View AllRecent Press Releases
Press Release on 02/09/12 at 9:00am
A Forward Look, the Year Ahead - Featured Research on BioMarin Pharmaceutical Inc. and Amylin Pharmaceuticals, Inc.
A Forward Look, the Year Ahead - Featured Research on BioMarin Pharmaceutical Inc. and Amylin Pharmaceuticals, Inc.
Press Release on 02/06/12 at 4:41pm
Amylin Pharmaceuticals Reports Fourth Quarter and Full Year 2011 Financial Results
Amylin Pharmaceuticals Reports Fourth Quarter and Full Year 2011 Financial Results
View AllRecent SEC Filings
View AllRecent Blog Posts
Blog Posts on 02/03/12 at 4:09am
Amylin Pharmaceuticals: There Are Better Investment Opportunities In Biotech
Amylin Pharmaceuticals: There Are Better Investment Opportunities In Biotech


